Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review

PDF  |  How to cite

Oncotarget. 2022; 13:985-985. https://doi.org/10.18632/oncotarget.28265

Metrics: PDF 546 views  |   ?  

Marco Rubatto1,*, Martina Merli1,*, Gianluca Avallone1, Andrea Agostini1, Luca Mastorino1, Virginia Caliendo1, Amelia Barcellini2, Viviana Vitolo2, Francesca Valvo2, Maria Teresa Fierro1, Simone Ribero1,# and Pietro Quaglino1,#

1Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy
2National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy
*Co-first authors
#Co-first senior authors

Published: August 04, 2022

Copyright: © 2022 Rubatto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Consent was added to this article: The patient mentioned in the paper signed the informed consent statement on 13/10/2020.

Original article: Oncotarget. 2021; 12:1116–1121. DOI: https://doi.org/10.18632/oncotarget.27966

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28265